Reduced-Dose Systemic Fibrinolysis in Massive Pulmonary Embolism: A Pilot Study
Ahmet Çağrı Aykan, Tayyar Gökdeniz, İlker Gül, Ezgi Kalaycıoğlu, Can Yücel Karabay, Faruk Boyacı, Engin Hatem, Scott D. Weingart, İhsan Dursun
Clin Exp Emerg Med. 2023;10(3):280-286.   Published online 2023 May 15     DOI: https://doi.org/10.15441/ceem.23.015
Citations to this article as recorded by Crossref logo
Safety and Efficacy of Reduced-Dose Versus Full-Dose Alteplase for Acute Pulmonary Embolism: A Multicenter Observational Comparative Effectiveness Study*
Roman Melamed, David M. Tierney, Ranran Xia, Caitlin S. Brown, Kristin C. Mara, Matthew Lillyblad, Abbey Sidebottom, Brandon M. Wiley, Ivan Khapov, Ognjen Gajic
Critical Care Medicine.2024; 52(5): 729.     CrossRef
Management of high-risk pulmonary embolism in the emergency department: A narrative review
Samuel G. Rouleau, Scott D. Casey, Christopher Kabrhel, David R. Vinson, Brit Long
The American Journal of Emergency Medicine.2024; 79: 1.     CrossRef
Addressing the rising trend of high‐risk pulmonary embolism mortality: Clinical and research priorities
Scott D. Casey, William B. Stubblefield, Dieuwke Luijten, Frederikus A. Klok, Lauren M. Westafer, David R. Vinson, Christopher Kabrhel
Academic Emergency Medicine.2024; 31(3): 288.     CrossRef
Shock Index and Physiological Stress Index for reestratifying patients with intermediate-high risk pulmonary embolism
Marcos Valiente Fernández, Amanda Lesmes González de Aledo, Francisco de Paula Delgado Moya, Isaías Martín Badía, Elena Álvaro Valiente, Nerea Blanco Otaegui, Pablo Risco Torres, Ignacio Saéz de la Fuente, Silvia Chacón Alves, Lidia Orejón García, María S
Medicina Intensiva (English Edition).2023;[Epub]     CrossRef